Oxford University Hospitals (OUH) has made a grant of £11.5 million to the University of Oxford, which the University will match with other funding, to allow the development of major clinical research facilities which have the potential to support the introduction of innovative and ground-breaking treatments for patients. Oxford is one of the most vibrant … Read more
Latest data on immune response to COVID-19 reinforces need for vaccination
A new study led by University of Oxford has found that previous infection, whether it was symptomatic or asymptomatic, does not necessarily protect you long term from COVID-19, particularly against new variants of concern. The PITCH Study (Protective Immunity from T cells to COVID-19 in Health workers) examined how the immune system responds to COVID-19 … Read more
Impaired antibody response to COVID-19 vaccination in patients with myeloid blood cancers
Oxford researchers have found that antibody responses to the first doses of COVID-19 vaccine in people with chronic myeloid blood cancers are not as strong as those among the general population. While this is expected to improve with the second dose, this important finding may help influence the design of future vaccination strategies, with further … Read more
Oxford wins government funding to evaluate prostate cancer detection system
A prostate cancer detection software system to help pathologists quickly identify suspicious areas of tissue, developed by the digital diagnostic company Paige, will be investigated in a multicentre clinical study led by the University of Oxford as part of a successful NHSX Artificial Intelligence Health and Care Award application. Paige Prostate automatically detects and highlights … Read more
Treating needle fears may reduce COVID-19 vaccine hesitancy
A new large-scale study shows that a quarter of the UK adult population has a potential injection phobia, and these individuals are twice as likely to be put off getting a COVID-19 vaccine. The study indicates that if all injection anxiety in the population was removed, just over 10 per cent of instances of vaccine … Read more
RECOVERY Trial identifies another effective COVID-19 treatment
The RECOVERY Trial, the world’s largest randomised trial of potential COVID-19 treatments, has found that a monoclonal antibody combination developed by US company Regeneron reduces deaths for hospitalised COVID-19 patients who have not mounted their own immune response. The RECOVERY Trial, which is led from Oxford and supported by the NIHR Oxford BRC, was established as a randomised … Read more
Professor Susan Jebb appointed as Chair of the Food Standards Agency
Professor Susan Jebb, the Oxford BRC’s Theme Lead for Obesity, Diet and Lifestyle, has been appointed as the new Chair of the Food Standards Agency. Prof Jebb, Professor of Diet and Population Health in Oxford University’s Nuffield Department of Primary Care Health Sciences, said: “I am delighted to be appointed to Chair the Food Standards … Read more
BRC-supported researchers recognised in Queen’s Birthday Honours
A number of NIHR Oxford BRC-supported researchers who have played prominent roles in the global response to the COVID-19 pandemic have been honoured as part of the Queen’s Birthday Honours List. The researchers, who have developed new vaccines or identified new drug treatments, have saved many lives around the world. Among the BRC researchers recognised … Read more
RECOVERY trial finds aspirin does not improve survival for hospitalised COVID-19 patients
The RECOVERY Trial, the world’s largest randomised trial of potential COVID-19 treatments, has found that in patients hospitalised with COVID-19, aspirin is not associated with reductions in mortality or in the risk of progressing to invasive mechanical ventilation or death. In results published on the pre-print server medRxiv, the trial team found that aspirin was associated with a small … Read more
AI endoscopy enables 3D surface measurements of pre-cancerous condition in oesophagus
Clinicians and engineers in Oxford have begun using artificial intelligence alongside endoscopy to get more accurate readings of the pre-cancerous condition Barrett’s oesophagus and so determine patients most at risk of developing cancer. In a research paper published in the journal Gastroenterology, the researchers said the new AI-driven 3D reconstruction of Barrett’s oesophagus achieved 97.2 … Read more
- 1
- 2
- 3
- …
- 64
- Next Page »